









Markets
/
Stocks
/
nasdaq-curx
/

Curanex Pharmaceuticals Inc

CURX

0.375USD

-0.020-5.14%

Close 12/19, 16:00（ET）Quotes delayed by 15 min

10.62MMarket Cap

LossP/E TTM



Curanex Pharmaceuticals Inc

0.375

-0.020-5.14%

Overview Company Financials Analysis

Overview

Company

Financials

Analysis

Cash Flow Statement

You can access the annual and quarterly cash flow statements of Curanex Pharmaceuticals Inc to evaluate its financial soundness and stability.

Quarterly

Quarterly+Annual

Quarterly

Annual

YOY

Hide blank rows

FY2025Q3

FY2025Q2

Operating cash flows (indirect method)

Cash flow from continuing operating activities

---9.19M

---290.08K

Net income from continuing operations

---954.06K

---60.35K

Other non-cash items

--15.44K

--15.03K

Change in working capital

---8.25M

---240.32K

-Change in prepaid expenses

---8.58M

--47.00

-Change in other current assets

--228.32K

---105.39K

Cash from non-recurring investing activities

Cash from operating activities

---9.19M

---290.08K

Investing cash flow

Cash from non-current investing activities

Financing cash flow

Cash flow from continuous financing activities

--14.91M

--200.00K

Net cash flow from debt Issuance/repayment

---400.00K

--200.00K

Net cash flow from common stock issuance/repurchase

--15.66M

----

Net cash flow from preferred stock issuance/repurchase

--0.00

----

Net cash flow from other financing activities

---346.50K

----

Net cash from non-recurrent financing activities

Net cash from financing activities

--14.91M

--200.00K

Net cash flow

Beginning cash balance

--108.86K

--198.94K

Current period cash flow changes

--5.72M

---90.08K

Ending cash balance

--5.83M

--108.86K

Currency unit

USD

Audit opinions

FAQs

What is the cash flow statement?



This report tracks the movement of cash into and out of the business, covering operating, investing, and financing activities. It highlights how well the company manages cash to support growth and meet its obligations.

KeyAI

